ABL/JAK Inhibitors With Chemotherapy and Venetoclax for Ph-like ALL
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
National Cancer Institute (NCI)
Daiichi Sankyo
St. Jude Children's Research Hospital
Syndax Pharmaceuticals
Assistance Publique - Hôpitaux de Paris
Beijing 302 Hospital
Mansoura University
Gruppo Italiano Malattie EMatologiche dell'Adulto
Alliance for Clinical Trials in Oncology
Gruppo Italiano Malattie EMatologiche dell'Adulto
Gruppo Italiano Malattie EMatologiche dell'Adulto
University of Nebraska
Daiichi Sankyo
Novartis
University College, London
Nanfang Hospital, Southern Medical University
AbbVie
Chinese PLA General Hospital
Brown University
AbbVie
University of Ulm
Technische Universität Dresden
Nohla Therapeutics, Inc.
University of Washington
St. Jude Children's Research Hospital
Fred Hutchinson Cancer Center
Peking University
University of Washington
University of Guadalajara
Chinese PLA General Hospital
Eastern Cooperative Oncology Group
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Swedish Orphan Biovitrum
Swedish Orphan Biovitrum
Children's Oncology Group
St. Jude Children's Research Hospital
Assistance Publique - Hôpitaux de Paris
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Pfizer
Pfizer
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Tehran University of Medical Sciences
Acute Leukemia French Association